Your Article Summary
See Latest ArticlesMetastasis of oral cancer to the parotid node
European Journal of Surgical Oncology, 06/26/09
Harada H et al. - In a trial to analyze the incidence and indicators of oral cancer metastases to the parotid node, it appears that metastasis to the parotid nodes should be considered in pts with oral cancer. Resection of the tail of the parotid gland is warranted during neck dissection.
Methods- The records of 253 pts with oral carcinomas who had undergone 289 neck dissections were reviewed.
- Histologic diagnoses of the primary tumors were squamous cell carcinoma in 239 pts, mucoepidermoid carcinoma in 5, adenoid cystic carcinoma in 4, and miscellaneous others in 5.
- In all neck dissections, the tail of the parotid gland below the marginal mandibular branch of the facial nerve was resected.
- The cervical and parotid lymph nodes were isolated from the surgical specimens.
- 1 section through the maximum cross-sectional area of each node was examined histologically.
- From 183 of the 289 neck specimens, 539 parotid nodes were collected: 222 extraglandular and 317 intraglandular.
- Of the 253 pts, 10 (4.0%) had 19 parotid node metastases, of which 4 were extraglandular and 15 intraglandular.
- Parotid node involvement occurred in 2.5% of oral squamous cell carcinoma cases.
- For the other cancers, there were too few cases to determine a meaningful frequency.
- In terms of indicators, likelihood of metastasis to the parotid nodes increased with number of cancer-positive cervical nodes.
Related Articles
Oral cancer and polymorphism of ethanol metabolising genes
Oral Oncology, 11/12/09
Relevance Score: 70%
Quantification of betel quid chewing and cigarette smoking in oral cancer patients
Community Dentistry and Oral Epidemiology, 11/17/09
Relevance Score: 69%
Transactivation and expression patterns of Jun and Fos/AP-1 super-family proteins in human oral cancer
International Journal of Cancer, 11/10/09
Relevance Score: 68%
Saliva as a tool for oral cancer diagnosis and prognosis
Oral Oncology, 10/21/09
Relevance Score: 68%
Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer
Journal of Clinical Oncology, 10/16/09
Relevance Score: 68%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Secondary surgery in paediatric facial paralysis reanimation
Journal of Plastic, Reconstructive & Aesthetic Surgery, 12/18/09
Can occlusal devices prolong the effect of botulinum toxin type A in the contouring of the lower face
European Journal of Plastic Surgery, 12/17/09
Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma
Journal of Gastroenterology, 12/15/09
Today in Surgical Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Prognostic Significance of Host- and Tumor-Related Factors in Patients with Gastric Cancer
World Journal of Surgery, 12/20/09
Comparative genomic hybridization for the diagnosis of melanoma
European Journal of Plastic Surgery, 12/20/09
Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy
Langenbeck's Archives of Surgery, 12/20/09